5Hussell T,Issaacson PG,Crabtre JE,et al.The response of cells from lowgrade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Heliobacter pylori.Lancet,1993,342:571～574.
6Morgner A,Bayerdorffer E,Neubauer A,et al.Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.Gastroenenterology Clin North Am,2000,29:593～607.
7Pinotti G,Zucca E,Roggero E,et al.Clinical feature,treatment andoutcome in aseries of 93 patients with low-grade gastric MALT lymphoma.Leuk Lymphomas,1997,26:527～537.
8Roggero E,Zucca E,Ponotti G,et al.Eradication of Helicobacter pylori infetion in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.Ann Intermrn Med,1995,122:767～769.
9Fend F,Schwaiger A,Weyrer K,et al.Early diagnosis of gastric lymphoma:gene rearrangement analysis of endoscopic biopsy samples.Leukemia,1994,8:35～39.
10Isaacson PG,Spenser J.Malignant lymphoma of mucosa-associated lymphoid tissue.Histopathology,1987,11:445～462.
同被引文献27
1The Non-Hodgkin's lymphoma Classification Project.Classification of non-Hodgkin's lymphomas:Reproducibility of major classification systems.Cancer,1985,55:91-95.
2Harris NL,Jaffe ES,Stein H,et al.A revised European-American classification of lymphoid neoplasms:a proposal from International Lymphoma study Group.Blood,1994,84:1361-1392.
3Harris NL,Jaffe ES,Diebold J,et al.World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues:report of the clinical advisory committee meeting-Airlie house,Virginia,November.J Clin Oncol,1999,17:3835 -3849.
4Jaffe ES,Harris NL,Stein H,et al.Tumours of Haematopoietic and Lymphoid Tissues.Lyon,France IARC,2001:204-207.
5Jaffe ES.Hematopathology:integration of morphologic features and biologic markers for diagnosis.Mod Pathol,1999,12:109 -115.
6Non-Hodgkin's Lymphoma Classification Project.A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma.Cancer,1997,89:3909-3918.
8Reiter A,Schrappe M,Ludwig WD,et al.Intensive ALL-type therapy without local radiotherpy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma:a BFM group report.Blood,2000,95:416-421.
9Young RC,Longo DL,Glatstein E,et al.The treatment of indolent lymphomas:watchful waiting versus aggressive combined modality treatment.Semin Hematol,1988,25:11-16.
10Khouri IF,Romaguera J,Kantarjian H,et al.Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation:an active regimen for aggressive mantle-cell lymphoma.J Clin Oncol,1998,16:3803-3809.
